ST. JUDE MEDICAL ANNOUNCES FDA APPROVAL OF EPIC II ICD AND EPIC II HEART FAILURE DEVICES

St. Jude Medical, Inc. today announced U.S. Food and Drug Administration (FDA) approval of its newest devices for treating patients with potentially lethal heart arrhythmias and heart failure. The EpicII ICD (implantable cardioverter defibrillator) and the Epic II HF CRT-D (cardiac resynchronization therapy defibrillator) devices feature significantly enhanced telemetry speed for faster device communications and a "patient notifier" that gently vibrates to alert patients of critical changes in device function. St. Jude Medical (http://phx.corporate-ir.net/test/phoenix.zhtml?c=73836&p=IROL-SingleRelease_print&t=NewsRelease&id=857183&highlight)